Theravance Biopharma Stock Market Value
TBPH Stock | USD 9.01 0.19 2.15% |
Symbol | Theravance |
Theravance Biopharma Price To Book Ratio
Is Theravance Biopharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Theravance Biopharma. If investors know Theravance will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Theravance Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.00) | Revenue Per Share 1.038 | Quarterly Revenue Growth 0.199 | Return On Assets (0.07) | Return On Equity (0.17) |
The market value of Theravance Biopharma is measured differently than its book value, which is the value of Theravance that is recorded on the company's balance sheet. Investors also form their own opinion of Theravance Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Theravance Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Theravance Biopharma's market value can be influenced by many factors that don't directly affect Theravance Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Theravance Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Theravance Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Theravance Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Theravance Biopharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Theravance Biopharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Theravance Biopharma.
02/27/2024 |
| 03/28/2024 |
If you would invest 0.00 in Theravance Biopharma on February 27, 2024 and sell it all today you would earn a total of 0.00 from holding Theravance Biopharma or generate 0.0% return on investment in Theravance Biopharma over 30 days. Theravance Biopharma is related to or competes with Agilent Technologies, Mustang Bio, Moleculin Biotech, Seres Therapeutics, Madrigal Pharmaceuticals, Equillium, and Kineta. Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines i... More
Theravance Biopharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Theravance Biopharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Theravance Biopharma upside and downside potential and time the market with a certain degree of confidence.
Information Ratio | (0.18) | |||
Maximum Drawdown | 13.26 | |||
Value At Risk | (3.60) | |||
Potential Upside | 3.29 |
Theravance Biopharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Theravance Biopharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Theravance Biopharma's standard deviation. In reality, there are many statistical measures that can use Theravance Biopharma historical prices to predict the future Theravance Biopharma's volatility.Risk Adjusted Performance | (0.06) | |||
Jensen Alpha | (0.24) | |||
Total Risk Alpha | (0.86) | |||
Treynor Ratio | 0.5478 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Theravance Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Theravance Biopharma Backtested Returns
Theravance Biopharma owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.13, which indicates the firm had a -0.13% return per unit of risk over the last 3 months. Theravance Biopharma exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Theravance Biopharma's Coefficient Of Variation of (815.77), risk adjusted performance of (0.06), and Variance of 5.99 to confirm the risk estimate we provide. The entity has a beta of -0.57, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Theravance Biopharma are expected to decrease at a much lower rate. During the bear market, Theravance Biopharma is likely to outperform the market. Theravance Biopharma has an expected return of -0.33%. Please make sure to validate Theravance Biopharma skewness, and the relationship between the treynor ratio and rate of daily change , to decide if Theravance Biopharma performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.71 |
Almost perfect reverse predictability
Theravance Biopharma has almost perfect reverse predictability. Overlapping area represents the amount of predictability between Theravance Biopharma time series from 27th of February 2024 to 13th of March 2024 and 13th of March 2024 to 28th of March 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Theravance Biopharma price movement. The serial correlation of -0.71 indicates that around 71.0% of current Theravance Biopharma price fluctuation can be explain by its past prices.
Correlation Coefficient | -0.71 | |
Spearman Rank Test | -0.71 | |
Residual Average | 0.0 | |
Price Variance | 0.02 |
Theravance Biopharma lagged returns against current returns
Autocorrelation, which is Theravance Biopharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Theravance Biopharma's stock expected returns. We can calculate the autocorrelation of Theravance Biopharma returns to help us make a trade decision. For example, suppose you find that Theravance Biopharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
Theravance Biopharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Theravance Biopharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Theravance Biopharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Theravance Biopharma stock over time.
Current vs Lagged Prices |
Timeline |
Theravance Biopharma Lagged Returns
When evaluating Theravance Biopharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Theravance Biopharma stock have on its future price. Theravance Biopharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Theravance Biopharma autocorrelation shows the relationship between Theravance Biopharma stock current value and its past values and can show if there is a momentum factor associated with investing in Theravance Biopharma.
Regressed Prices |
Timeline |
Currently Active Assets on Macroaxis
When determining whether Theravance Biopharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Theravance Biopharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Theravance Biopharma Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Theravance Biopharma Stock:Check out Theravance Biopharma Correlation, Theravance Biopharma Volatility and Theravance Biopharma Alpha and Beta module to complement your research on Theravance Biopharma. For more detail on how to invest in Theravance Stock please use our How to Invest in Theravance Biopharma guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Complementary Tools for Theravance Stock analysis
When running Theravance Biopharma's price analysis, check to measure Theravance Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theravance Biopharma is operating at the current time. Most of Theravance Biopharma's value examination focuses on studying past and present price action to predict the probability of Theravance Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theravance Biopharma's price. Additionally, you may evaluate how the addition of Theravance Biopharma to your portfolios can decrease your overall portfolio volatility.
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |
Theravance Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.